Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Puerarin Supplementation on Cardiovascular Disease Risk Factors in Men: a Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial

NCT03676296 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03676296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Puerarin Supplementation on Cardiovascular Disease Risk Factors in Men: a Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Completed
Start date
September 5, 2018
Completion date
April 17, 2021
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease risk factors